Award
NIH Reporter #11406764
Preclinical development of a novel therapeutic for Parkinson's disease
Recipient
SINOPIA BIOSCIENCES, INC.
Award Amount
$3,000,000.00
Ceiling
$3,000,000.00
Awarded
September 07, 2026
Identifier
11406764
Award for preclinical drug development targeting Parkinson's Disease, including toxicology studies and IND preparation, funded by NINDS.
Description
The project involves preclinical drug development for Parkinson's Disease, aiming to complete toxicology studies and prepare for IND submission. Funded by the National Institute of Neurological Disorders and Stroke.